Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Management of corneal ectasia after LASIK with combined, same-day, topography-guided partial transepithelial PRK and collagen cross-linking

Poster Details

First Author: S.Goel INDIA

Co Author(s):    S. Mukherjee   A. Shastri           

Abstract Details



Purpose:

To evaluate a series of patients with corneal ectasia after LASIK that underwent the Athens Protocol: combined topography-guided photorefractive keratectomy (PRK) to reduce or eliminate induced myopia and astigmatism followed by sequential, same-day ultraviolet A (UVA) corneal collagen cross-linking (CXL).

Setting:

Anand Eye Hospital, Jaipur, Rajasthan.

Methods:

Twelve eyes with corneal ectasia underwent transepithelial PRK immediately followed by CXL (3 mW/cm2) for 30 minutes using 0.1% topical riboflavin sodium phosphate. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction, spherical equivalent, keratometry, pachymetry, corneal topography(ATLAS Carl Zeiss) were analyzed over a period of 18 months.

Results:

9 out of 12 eyes had an improvement in UDVA and CDVA of 20/45 or better (2.25 logMAR) at last follow-up. Four eyes showed some topographic improvement but no improvement in CDVA. One of the treated eyes required a subsequent penetrating keratoplasty. Corneal haze grade 2 was present in 2 eyes.

Conclusions:

: Combined, same-day, topography-guided PRK and CXL appeared to offer topographic stability, even after long-term follow-up. This technique may offer an alternative in the management of iatrogenic corneal ectasia. FINANCIAL INTEREST: NONE

Back to Poster listing